ACCESSION: MSBNK-SMB_Measured-HSA001P0087009
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'14_posi_6534': {'bp': 223654.0, 'sum': 591594.0}, '16_posi_5854': {'bp': 163786.0, 'sum': 456581.0}, '17_posi_6028': {'bp': 172803.0, 'sum': 500168.0}, '16_posi_6620': {'bp': 178806.0, 'sum': 535545.0}, '17_posi_6169': {'bp': 185941.0, 'sum': 523915.0}, '15_posi_6407': {'bp': 187486.0, 'sum': 530023.0}, '16_posi_6155': {'bp': 170278.0, 'sum': 489386.0}, '18_posi_6215': {'bp': 175719.0, 'sum': 510346.0}, '17_posi_6091': {'bp': 179844.0, 'sum': 505433.0}, '18_posi_6547': {'bp': 182832.0, 'sum': 496927.0}, '16_posi_6343': {'bp': 177201.0, 'sum': 499050.0}, '16_posi_6283': {'bp': 183621.0, 'sum': 540118.0}, '19_posi_6171': {'bp': 155907.0, 'sum': 491818.0}, '18_posi_5920': {'bp': 170255.0, 'sum': 483689.0}, '16_posi_6821': {'bp': 184420.0, 'sum': 516840.0}, '17_posi_6545': {'bp': 207867.0, 'sum': 558540.0}, '15_posi_6660': {'bp': 200969.0, 'sum': 536822.0}, '19_posi_5920': {'bp': 162421.0, 'sum': 477716.0}, '18_posi_6324': {'bp': 192455.0, 'sum': 524940.0}, '19_posi_6428': {'bp': 165912.0, 'sum': 486538.0}, '13_posi_6575': {'bp': 203581.0, 'sum': 618419.0}, '18_posi_5839': {'bp': 155243.0, 'sum': 463337.0}, '19_posi_5988': {'bp': 151350.0, 'sum': 447397.0}, '19_posi_6074': {'bp': 172657.0, 'sum': 476576.0}}
COMMENT: RETENTION_TIME_STDEV 0.562
COMMENT: PRECURSOR_M/Z_RAW 87.092001
COMMENT: PRECURSOR_M/Z_STDEV 0.000029
COMMENT: PRECURSOR_IN_MS1 mz 87.091664; int 254.628; delta(ppm) 1.328233
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 104.118186; int 432.291; cor 0.698
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.046; C4H10N2; [M+H]+; delta(ppm) -0.046466
COMMENT: PROPOSED_MF MS-FINDER 3.791; C4H10N2; [M+H]+; delta(ppm) -0.054721
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.676; C4H10N2; [M+H]+; delta(ppm) -0.054721
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H10N2; [M+H]+; delta(ppm) -0.054721
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.117; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.857; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.839; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.815; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.787; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.787; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.767; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.648; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.745; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.745; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.745; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.745; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.745; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.501; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.501; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.501; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.454; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; HQFQTTNMBUPQAY-UHFFFAOYSA-N; [M+H]+; cyclobutylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.147; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; FBFGFCAGFFHMPG-UHFFFAOYSA-N; [M+H]+; cyclopropylmethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; JYQKJYDDOGBPOA-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-1-methylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; HBRZQKXSEKTPEW-UHFFFAOYSA-N; [M+H]+; but-3-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; WKWPTGYQIHKPSJ-UHFFFAOYSA-N; [M+H]+; 2-methylprop-2-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.968; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; BIWZYRJXBPPLLA-UHFFFAOYSA-N; [M+H]+; 1-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; UYLSVYARXBFEKV-UHFFFAOYSA-N; [M+H]+; cyclobutane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; FPYGTMVTDDBHRP-OWOJBTEDSA-N; [M+H]+; (E)-but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; VMAXJDJIFGIBGH-UHFFFAOYSA-N; [M+H]+; azetidin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; MRYNEEIGLSDRKH-UHFFFAOYSA-N; [M+H]+; azetidin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; JATTWGKYNBEIMH-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; PYBBRDLRXFWWFU-UHFFFAOYSA-N; [M+H]+; 3-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; PRCGMIFKQRXNBS-UHFFFAOYSA-N; [M+H]+; 2-methylidenepropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; VHCQWQAYVBRQQC-ZXZARUISSA-N; [M+H]+; (1R,2S)-cyclobutane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; HTFFABIIOAKIBH-UHFFFAOYSA-N; [M+H]+; diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.685; MLTKZVHOZAKJMV-UHFFFAOYSA-N; [M+H]+; 3-ethyl-3-methyldiaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.682; SPPFMFXKGYNRER-UHFFFAOYSA-N; [M+H]+; 4-methylpyrazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.637; PAXRVGDTBDATMF-UHFFFAOYSA-N; [M+H]+; N,N-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.629; SVKQJKDFMLYPSM-UHFFFAOYSA-N; [M+H]+; N'-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.629; NQPTWMKTGPWPMX-UHFFFAOYSA-N; [M+H]+; N-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.257; INTMMHZKGCDQGT-UHFFFAOYSA-N; [M+H]+; diethyldiazene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.132; JMHYNOCZNRXMLN-UHFFFAOYSA-N; [M+H]+; N,N'-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; FDWQPDLACZBQBC-PLNGDYQASA-N; [M+H]+; N-[(Z)-ethylideneamino]-N-methylmethanamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H11N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 12.569
MS$FOCUSED_ION: PRECURSOR_M/Z 87.091670
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0079-9000000000-987a169de077712d8354
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0386498 18.8720 53.039272 1.5460 3.60 -0.2132 17 f{C4H5}/1.38ppm,p-H6N2
  58.0651760 37.2007 58.065812 1.1194 7.11 -0.2522 24 f{C3H8N1}/0.87ppm,p-C1H3N1
  60.0444198 29.4065 60.045059 1.0659 14.16 0.0998 23 ?
  70.0651380 999.0000 70.065758 0.2997 5.63 0.8530 24 f{C4H8N1}/0.18ppm,p-H3N1
  87.0440946 440.8687 87.044548 0.4136 57.45 -0.4035 24 ?
  87.0553081 211.8484 87.055762 0.5858 50.31 0.5965 24 ?
  87.0632765 148.4825 87.063730 0.7236 20.37 0.0070 24 ?
  87.0916969 897.5478 87.092150 0.3100 58.71 1.0000 24 f{C4H11N2}/0.25ppm,p
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  53.038650 18.87 18
  58.065176 37.20 37
  60.044420 29.41 29
  70.065138 999.00 999
  87.044095 440.87 440
  87.055308 211.85 211
  87.063277 148.48 148
  87.091697 897.55 897
//
